Oxycodone
Eija Kalso, Eija Kalso
Abstract
Oxycodone has been in clinical use since 1917. Parenteral oxycodone was used mainly for the treatment of acute postoperative pain whereas combinations, for example, oxycodone and acetaminophen, were used for moderate pain. Since the introduction of controlled-release oxycodone, it has been used to manage cancer-related pain and chronic non-cancer-related pain problems. Controlled studies have been performed in postoperative pain, cancer pain, osteoarthritis-related pain, and neuropathic pain due to postherpetic neuralgia and diabetic neuropathy. The pharmacodynamic effects of oxycodone are typical of a mu-opioid agonist. Oxycodone closely resembles morphine but it has some distinct differences, particularly in its pharmacokinetic profile. Being an old drug, the basic pharmacology of oxycodone has been a neglected field of research.
Source: PubMed
Upcoming Clinical Trials
-
NCT07923474Not yet recruiting
-
NCT07923578Not yet recruiting
-
NCT07894926Recruiting
-
NCT07923448Not yet recruiting
-
NCT07903701Not yet recruitingAcute Ischemic Stroke AIS
-
NCT07921680Not yet recruitingNasal Obstruction | Bronchiolitis | Acute Upper Respiratory Tract Infections
-
NCT07921329Recruiting
-
NCT07893639Not yet recruitingExtracorporeal Membrane Oxygenation Complication | ECMO Cannula Infection
-
NCT07923214RecruitingBreast Cancer | Gastric Cancer | Ovarian Cancer | Advanced Solid Tumors | Other Solid Tumors
-
NCT07921537Not yet recruitingAdult Carriers of a Pathogenic or Probably Pathogenic (Class 4 and 5) Germline Variation in the TP53 Gene
-
NCT06594536Recruiting
-
NCT07923110Not yet recruitingPost Operative Pain, Acute | Irreversible Pulpitis (Toothache) | Pulp Necrosis, Apical Periodontitis